Carfilzomib weekly 20/56 mg/m 2 , lenalidomide and dexamethasone for early relapsed refractory multiple myeloma.

Authors :: Richez V
Gruchet C
Guidez S
Fouquet G
Azais I
Durand G
Javaugue V
Brigaud A
Plasse F
Diolez J
Machet A
Moya N
Gardeney H
Franques P
Bobin A
Levy A
Sabirou F
Bonnin A
Dieval C
Primault S
Barrier J
Fleck E
Bouyier S
Daras C
Princet I
Bauwens D
Legros L
Fuzibet JG
Gil A
Bridoux F
Avet-Loiseau H
Leleu X
Source :: American journal of hematology [Am J Hematol] 2019 Jan; Vol. 94 (1), pp. E17-E20. Date of Electronic Publication: 2018 Nov 25.
Publication Year :: 2019

Subjects :: Aged
Aged, 80 and over
Dexamethasone administration & dosage
Drug Administration Schedule
Female
Humans
Kaplan-Meier Estimate
Lenalidomide administration & dosage
Male
Middle Aged
Oligopeptides administration & dosage
Progression-Free Survival
Recurrence
Salvage Therapy
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Multiple Myeloma drug therapy

Full Text Access

Tools